Comprehensive analysis of Tata Focused Fund (IDCW) (40930) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Tata Asset Management Ltd
The investment objective of the scheme is to generate long term capital appreciation by investing in equity & equity related instruments of maximum 30 stocks across market caps. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Weak Returns
High Risk
High Expenses
Equity Focused
Seasoned Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Market exposure level
Outperformance vs benchmark
Historical performance consistency
Fund manager experience
Recent performance momentum
Assets under management
Risk-adjusted returns
Fund management costs
This fund has outperformed its benchmark by 0.21% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| HDFC Bank Ltd | Banks | 9.81% |
| Tech Mahindra Ltd | IT - Software | 7.82% |
| Axis Bank Ltd | Banks | 6.72% |
| Reverse Repo | Debt Others | 6.69% |
| ICICI Bank Ltd | Banks | 5.75% |
| Reliance Industries Ltd | Refineries | 4.24% |
| Firstsource Solutions Ltd | IT - Software | 3.69% |
| Apollo Hospitals Enterprise Ltd | Healthcare | 3.65% |
| Net CA & Others | Debt Others | 3.09% |
| Alkem Laboratories Ltd | Pharmaceuticals | 2.91% |
Compare against Focused Fund category average
This comparison shows how the fund performs relative to the Focused Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Focused Fund category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| SBI Focused Fund - Direct (G) | ₹397.05 | 15.40% | 6.49% | 16.25% |
| SBI Focused Fund (G) | ₹353.30 | 14.94% | 5.64% | 15.25% |
| HDFC Focused Fund - Direct (G) | ₹262.54 | 15.49% | 7.14% | 23.76% |
| HDFC Focused Fund - Regular (G) | ₹231.24 | 14.90% | 6.03% | 22.28% |
| Sundaram Focused Fund - Direct (G) | ₹176.05 | 10.43% | -4.16% | 14.21% |
| Sundaram Focused Fund (G) | ₹158.77 | 9.90% | -5.08% | 13.03% |
| Aditya Birla SL Focused Fund-Direct (G) | ₹156.85 | 12.89% | -1.00% | 16.22% |
| Aditya Birla SL Focused Fund (G) | ₹139.07 | 12.37% | -1.91% | 15.12% |
| Nippon India Focused Fund - Direct (G) | ₹131.52 | 15.74% | -2.02% | 14.69% |
| Franklin India Focused Equity Fund - Direct (G) | ₹121.77 | 14.52% | -1.46% | 17.35% |
A seasoned investment professional with over 6 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.